UroGen Pharma Ltd. (URGN) Earnings History
Net Loss13 years of earnings data (2013–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
UroGen Pharma Ltd. (URGN) Earnings Overview
As of October 10, 2026, UroGen Pharma Ltd. (URGN) reported trailing twelve-month net income of -$98M, reflecting -7.8% year-over-year growth. The company earned $-1.94 per diluted share over the past four quarters, with a net profit margin of -139.8%.
Looking at the long-term picture, URGN's historical earnings data spans multiple years. The company achieved its highest annual net income of -$2M in fiscal 2016.
UroGen Pharma Ltd. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including PCVX (-$1.06B net income), SUPN (-$110M net income, -5.4% margin), PRGO (-$1.73B net income, -33.5% margin), URGN has comparable earnings metrics. Compare URGN vs PCVX →
URGN Earnings vs Peers
Earnings metrics vs comparable public companies
URGN Historical Earnings Data (2013–2025)
13 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$153M | -21.0% | -$125M | $-3.19 | -139.8% | -113.7% |
| 2024 | -$127M | -24.1% | -$97M | $-2.96 | -140.4% | -107.1% |
| 2023 | -$102M | +6.9% | -$66M | $-3.55 | -123.6% | -79.2% |
| 2022 | -$110M | +0.9% | -$79M | $-4.79 | -170.6% | -122.8% |
| 2021 | -$111M | +13.7% | -$92M | $-4.96 | -230.7% | -192.1% |
| 2020 | -$128M | -22.2% | -$127M | $-5.90 | -1088.9% | -1074.2% |
| 2019 | -$105M | -39.0% | -$109M | $-4.90 | -584144.4% | -608211.1% |
| 2018 | -$76M | -278.3% | -$77M | $-4.80 | -6707.2% | -6842.2% |
| 2017 | -$20M | -930.4% | -$20M | $-2.06 | -245.2% | -244.5% |
| 2016 | -$2M | +84.7% | $798,000 | $-0.16 | -11.1% | 4.6% |
| 2015 | -$13M | -178.5% | -$12M | $-5.51 | - | - |
| 2014 | -$5M | -37.8% | -$4M | $-1.98 | - | - |
| 2013 | -$3M | - | -$3M | $-1.56 | - | - |
Download Data
Export URGN earnings history in CSV or JSON format
Free sign-in required to download data
URGN Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
13+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
URGN — Frequently Asked Questions
Quick answers to the most common questions about buying URGN stock.
What is URGN earnings per share (EPS)?
URGN trailing twelve-month (TTM) diluted EPS is $-1.94, reflecting -7.8% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2013 to 2025 is available in the table on this page.
What is UroGen Pharma Ltd.'s net income?
UroGen Pharma Ltd. (URGN) trailing twelve-month net income is $-98M as of 2025. Earnings declined -7.8% year-over-year.
Is URGN profitable?
URGN is not currently profitable on a TTM basis, reporting a net loss of $-98M. Net margin is -139.8%. Investors should monitor for a return to profitability.
What is URGN's earnings growth rate?
URGN compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2013 to 2025.
What are URGN's profit margins?
UroGen Pharma Ltd. net profit margin is -139.8%, operating margin is -113.7%, and gross margin is +88.7%. Below-average margins reflect competitive or cost pressures. Return on Equity is N/A.
Is URGN growing earnings?
URGN earnings are declining — EPS fell -7.8% year-over-year. TTM net income dropped to $-98M. This contrasts with the 5-year CAGR of N/A.
What was URGN's best earnings year?
UroGen Pharma Ltd.'s highest annual net income on record is $-2M, achieved in fiscal year 2016. Earnings history on this page spans 2013 to 2025 and includes all annual and quarterly figures.
What were URGN's earnings last quarter?
URGN's most recent reported quarter was Q2 2026. Net income was $-14M with diluted EPS of $-0.28. For a full breakdown of all quarters, see the quarterly earnings table on this page.